Prelude Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,160
Closed -$301K 1139
2025
Q2
$301K Buy
+23,160
New +$274K 0.03% 611
2024
Q4
Sell
-12,519
Closed -$291K 1211
2024
Q3
$291K Buy
12,519
+533
+4% +$11.4K 0.02% 884
2024
Q2
$292K Buy
+11,986
New +$363K 0.02% 805
2024
Q1
Sell
-9,359
Closed -$295K 1307
2023
Q4
$295K Buy
9,359
+897
+11% +$21.3K 0.03% 744
2023
Q3
$216K Sell
8,462
-364
-4% -$11.2K 0.02% 855
2023
Q2
$253K Sell
8,826
-3,768
-30% -$103K 0.02% 724
2023
Q1
$302K Buy
+12,594
New +$226K 0.02% 640
2022
Q3
Sell
-11,753
Closed -$185K 1569
2022
Q2
$185K Buy
+11,753
New +$231K 0.01% 1308
2020
Q4
Sell
-5,727
Closed -$388K 1296
2020
Q3
$246K Sell
5,727
-2,073
-27% -$103K 0.03% 622
2020
Q2
$365K Sell
7,800
-23,539
-75% -$811K 0.06% 564
2020
Q1
$426K Buy
31,339
+478
+2% +$6.12K 0.1% 339
2019
Q4
$335K Buy
30,861
+8,231
+36% +$86.2K 0.04% 682
2019
Q3
$232K Buy
22,630
+5,113
+29% +$55.3K 0.03% 723
2019
Q2
$165K Sell
17,517
-7,272
-29% -$53.4K 0.02% 796
2019
Q1
$169K Buy
+24,789
New +$127K 0.02% 771
2018
Q3
Sell
-1,100
Closed -$9K 1720
2018
Q2
$9K Buy
+1,100
New +$7.12K ﹤0.01% 1498
2017
Q4
Sell
-1,171
Closed -$8K 1353
2017
Q3
$8K Buy
1,171
+1,157
+8,264% +$8.72K ﹤0.01% 1451
2017
Q2
$0 Buy
+14
New +$113 ﹤0.01% 1593
2016
Q3
Sell
-29
Closed -$1K 1580
2016
Q2
$1K Buy
+29
New +$914 ﹤0.01% 1527
2014
Q4
Sell
-29
Closed -$3K 1885
2014
Q3
$3K Sell
29
-357
-92% -$46.5K ﹤0.01% 1820
2014
Q2
$47K Sell
386
-785
-67% -$94.8K 0.01% 1375
2014
Q1
$149K Buy
+1,171
New +$174K 0.03% 841
2013
Q4
Sell
-200
Closed -$25K 1609
2013
Q3
$25K Buy
+200
New +$17.8K 0.01% 1202

Other funds holding ARCT